International Journal of Infectious Diseases

Papers
(The H4-Index of International Journal of Infectious Diseases is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era609
The contributions of vaccination and natural infection to the production of neutralizing antibodies against the SARS-CoV-2 prototype strain and variants478
Prevalence of hepatitis B virus infection in pregnant women with and without HIV in Jos, Nigeria313
Antimicrobial resistance patterns in bacteria causing febrile illness in Africa, South Asia, and Southeast Asia: a systematic review of published etiological studies from 1980-2015249
From Mapping to Elimination: A Comprehensive Overview of Rwanda's Schistosomiasis Program247
Impact of interventions on mpox transmission during the 2022 outbreak in Canada: a mathematical modeling study of three different cities208
Human Metapneumovirus in China: A Wake-Up Call for Resilient Healthcare Systems and Rapid Response193
Bridging the Last Mile: The Critical Role of Local Civil Society in Advancing Equity and Inclusion for Neglected Tropical Diseases184
Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide Consortium to Investigate Host Genetics of COVID-19181
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA network175
COVID-19-related myocarditis post-heart transplantation165
Indispensable yet invisible: A qualitative study of the roles of carers in infection prevention in a South Indian hospital163
Patient understanding of and participation in infection-related care across surgical pathways: a scoping review161
Efficacy of infliximab, abatacept, and cenicriviroc for the treatment of adults hospitalized with COVID-19 pneumonia146
High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19143
Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study136
Impact of routine bedside infectious diseases service on clinical management and prognosis of patients with Candida fungemia – an example for Antifungal Stewardship at university level in Germany124
Fatal cases after Omicron BA.1 and BA.2 infection: Results of an autopsy study119
Potential determinants of the decline in mpox cases in Belgium: A behavioral, epidemiological and seroprevalence study116
COVID-19: Autopsy findings in six patients between 26 and 46 years of age110
Xpert MTB/RIF Ultra outperformed the Xpert assay in tuberculosis lymphadenitis diagnosis: a prospective head-to-head cohort study108
Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries99
Editorial Board94
Nocardial brain abscess in a patient with AIDS94
Should remdesivir be recommended in France in the early stage of COVID-1993
High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin87
Epidemiologic patterns of hepatitis A infection during the pre–vaccination era: A population-based survey in Tunisia in 201582
Pseudotumor of the skin due to Mycobacterium genavense82
Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities78
THE GENOMIC POPULATION STUDY OF BLOODSTREAM ASSOCIATED ESCHERICHIA COLI IN 2020 IN SOUTHWEST, UK78
Multidrug-resistant tuberculosis in children: Are the same therapy options available worldwide?76
Editorial Board76
Risk of lymphoid malignancies increased after Puumala virus infection in Finland, 2009-2019: A retrospective register-based cohort study74
Exclude differentials before diagnosing SARS-CoV-2-associated acute haemorrhagic necrotising encephalitis72
A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients72
Association Between Pneumonia and Chronic Otitis Media: A Nested Case-Control Study Using a National Health Screening Cohort70
CENTRAL NERVOUS SYSTEM TUBERCULOSIS IMMUNOPATHOLOGY IS DRIVEN BY MATRIX DESTRUCTION WITH MATRIX METALLOPROTEINASES INHIBITION REDUCING INFLAMMATION AND IMPROVING SURVIVAL69
Editorial Board69
NUCLEOSIDE-MODIFIED MRNA VACCINES PROTECT IFNAR -/- MICE AGAINST CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS INFECTION68
THE CONTEXT OF ANTIBIOTIC USE IN BROILER POULTRY FARMS IN BANGLADESH: A QUALITATIVE EXPLORATION67
PREVALENCE OF ASYMPTOMATIC LEISHMANIA INFECTION IN PEOPLE LIVING WITH HIV AND PROGRESSION TO SYMPTOMATIC VISCERAL LEISHMANIASIS IN BIHAR, INDIA65
DENGUE MICROEVOLUTIONARY PROCESSES IN WOLBACHIA-INFECTED MOSQUITO CELL LINES65
BURDEN AND SEVERITY OF COVID-19 IN CHILDREN HOSPITALISED OVER FIVE COVID-19 WAVES IN SOWETO, SOUTH AFRICA62
RECALLING IMMUNE RESPONSES POST VISCERAL LEISHMANIASIS62
MAPPING TEAM DYNAMICS AND TRAFFIC IN THE OPERATING THEATRE: IDENTIFICATION OF ROLES AND STRESSORS IN INFECTION RELATED PRACTICE AND ITS COMMUNICATION WITH SURGICAL TEAMS61
IN-HOSPITAL MORTALITY OF HEART FAILURE PATIENTS ASSOCIATED WITH COMMUNITY-ACQUIRED SEPSIS AND HOSPITAL-ACQUIRED SEPSIS60
AN ESTERASE-LIKE PROTEIN (ELP) CONFERRED MALATHION AND DELTAMETHRIN RESISTANCE IN THE INDIAN FIELD POPULATION OF ANOPHELES STEPHENSI59
ZOONOSIS AS A CAUSE OF ACUTE FEBRILE ILLNESS AT A ONE HEALTH INTERFACE IN RURAL SOUTH AFRICA: IT'S THE LITTLE FIVE, NOT THE BIG FIVE59
THE USE OF IMAGERY IN GLOBAL HEALTH: AN ANALYSIS OF INFECTIOUS DISEASE DOCUMENTS AND A FRAMEWORK FOR ETHICAL STANDARDS59
ANTIVIRAL STRATEGIES FOR HUMAN ENTEROVIRUSES58
COVID-19: A MULTI-HOST PANDEMIC58
BACTERIAL INFECTIOUS DISEASES IN THE COVID-19 ERA58
Severe Outcomes, Readmission, and Length of Stay Among COVID-19 Patients with Intellectual and Developmental Disabilities56
PATIENT-CENTERED SURVEILLANCE OF DRUG-RESISTANT INFECTIONS56
SPOTTING UNSEEN OUTBREAKS USING WG56
RESURGENCE OF SYPHILIS56
0.4735119342804